Rosacea Support Group » seborrheic dermatitis

Extina, Ketoconazole you can use on your face

David Pascoe — Fri, 27 Aug 2010 10:45:03 +0000

A formulation of Ketoconazole 2% for treating seborrheic dermatitis called Extina is currently being promoted by Stiefel Laboratories.

Stiefel, which is a part of GSK, is promoting Extina as the “first and only ketoconazole foam for scalp, body, and face” and being “proven for hair, there and everywhere”.

This foam-based formulation is potentially interesting because it is being promoted as approved for use on facial skin.

The formulation is described as a thermoliable hydroethanolic foam (also known as VersaFoam-HF). The prescribing information advises against dispensing the foam in your hands as it will being to `melt’ immediately. Instead, users are told to dispense the foam into the cap or another cold surface and use fingertips to gently massage into the affected area.

Officially, the reason that ketoconazole works when treating seborrheic dermatitis is unknown.

Active ingredients: ketoconazole

Inactive Ingredients: cetyl alcohol, citric acid, ethanol (denatured with tert-butyl alcohol and brucine sulfate) 58%, polysorbate 60, potassium citrate, propylene glycol, purified water, and stearyl alcohol pressurized with a hydrocarbon (propane/butane) pro

See the Extina web site for the prescribing information and safety warnings.

Clarifoam EF good for Rosacea, Acne and Seborrheic Dermatitis

David Pascoe — Fri, 19 Mar 2010 10:30:02 +0000

This just published paper details a `new’ product that comprises a slight twist on an old formula. It seems that much of modern research and development involves tweaking existing treatments to see how their efficacy and product lifecycle can be extended.

This new product is known as CLARIFOAM EF Emollient Foam, and is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. The company web site boldly claims that Clarifoam EF effectively treats all 3 conditions.

In combination with sulfacetamide, sulfur has been reported to inhibit the growth of Propionibacterium acnes thereby reducing the inflammation associated with acne.

The active ingredients of Clarifoam EF are a combination of 10% sodium sulfacetamide and 5% sulfur.

The Clarifoam Prescribing Information mentions two forms of application: The Wash-Off application and the Leave-On application. The Wash-Off application suggests a 10 minute application 1-3 times a day to clean dry skin and rinsing thoroughly with water. The Leave-On application suggests the same 1-3 times a day, but wiping off any excess and otherwise leaving the foam application untouched.

The product comes in an aluminium can which needs to be primed before its first use and shaken vigorously before each use. A Clarifoam Rebate Coupon of up to $30 is available until the end of December 2010.

Here is the abstract of the study suggesting that Clarifoam is useful in treat the 3 conditions at once.

Dr. Draelos is well known to rosacea sufferers being on the expert panel that recently published the Standard Rosacea Management Options, the Cetaphil Cleansing Bar and Cetaphil Gentle Skin Cleanser, Clarisonic as well as cleansing and the management of rosacea.

The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses. J Drugs Dermatol. 2010 Mar;9(3):234-6., Draelos ZD.

Prior to 1962, some of the most versatile drugs in dermatology were approved by the U.S. Food and Drug Administration (FDA) solely on the basis of safety.

One of these is the combination 10% sodium sulfacetamide and 5% sulfur. Sodium sulfacetamide possesses anti-inflammatory and antibacterial properties while sulfur is a nonspecific antibacterial and antifungal. A new emollient foam formulation of 10% sodium sulfacetamide and 5% sulfur allows a thinner application film and leaves behind no residue on hair bearing or non-hair bearing skin. The sulfur smell is also more quickly dissipated with reduced irritation.

This uncontrolled, observational, prospective, open-label, single site, eight-week study enrolled 24 subjects (eight with rosacea, eight with seborrheic dermatitis, eight with acne vulgaris) to evaluate the safety and efficacy of this novel foam formulation.

At eight weeks, statistically significant improvement was seen in inflammatory rosacea lesion counts and the signs of seborrheic dermatitis. A 50% reduction was noted in the total acne lesion counts. These findings confirm the versatility of an emollient 10% sodium sulfacetamide and 5% sulfur foam.

Clarifoam EF is made by Onset Therapeutics which is a subsidary of Collegium Pharmaceutical.

Other products that also feature a combination of Sodium Sulfacetamide and Sulfur include: Clenia, Rosaderm, Plexion, Ovace, Klaron, Rosanil, Rosac and Rosula. Yes indeed there is a lot of products you can choose should you wish to try out a formulation of these two actives.

User Reviews

Nora in the thread Clarifoam at the Rosacea Support Community;… However, he gave me a sample of Clarifoam and I used it for about 4 days. It made my skin so dry and chapped it was painful. I tried rinsing it off after application as the website says, but that didn’t help. I stopped using it and had to use Aquaphor for a few days to lubricate my skin. So, I guess this is not for me!!
harrysinghnyc in the thread Clarifoam at the Rosacea Form;I have tried pro-topic, metrogel and locoid lipocream and none could remedy my seb derm but today is the 2nd day I have applied clarifoam and i notice that the outbreak is 90% gone! I have never had this type of turnaround this fast! One day after using it, i am prescribed this foam lotion 2x daily, so this is awesome!
rf11 in the thread My rosacea is gone!! at the Rosacea Forum;Anyway, to update, I have been using clarifoam and Cerave soap for almost a month now, and my skin looks better than it has in years.
J-Mill in the thread clarifoam ef at the Rosacea Forum;I have tried this stuff recently and really like it. … In short, both medications attack some key Rosacea/Seb Derm aggravators. What I like about Clarifoam is I find the base really non-irritating, unlike most topicals I have tried. Everyone is different though and as always you should test patch topicals, especially one with sulfacetamide as some peopl are very allergic to it.
fyd in the the thread Clarifoam EF is the greatest! at the acne.org message board;… on Christmas eve my derm prescribed me with this stuff. He said that they were making my face look much more worse than it was and he was absolutely right. This product just came out about a month ago, so it’s brand new. I started using it on Christmas and in about a week and a half to 2 weeks, i saw a big difference. They were fading away, I couldnt believe it! To be honest, i couldnt stop smiling at what my face looked like. Now, they are very much still there, but very faint and they are starting to blend in very nicely. They are more of a light brown then red now. Ziana and Clarifoam are working great together.

Product Page: Clarifoam EF
RSRP: Sulfur / Sodium Sulfacetamide Topicals

Promiseb even better than Desonide 0.05%

David Pascoe — Thu, 26 Nov 2009 01:47:06 +0000

Promiseb Topical Cream has been found to be as effective as desonide cream 0.05% when treating facial dermatitis. This is an exciting finding, especially if the results can be replicated at large in the rosacea / seborrheic dermatitis community.

Rosacea sufferers are well advised to be careful with any form of steroids because it has been shown that even over the counter steroids can cause steroid induced rosacea.

Those using the Promiseb Cream, who experienced cleared symptoms after 14 days, were more likely to stay clear for another 14 days after ceasing, compared to the Desonide Cream. This result is encouraging as it suggests that the benefit from Promiseb is more sustainable compared to even low strength topical steroids. Thus it seems from this study that Promiseb is indeed a better treatment than Desonide for mild to moderate seborrheic dermatitis.

Promiseb Topical Cream (Sebclair) is a non-steroidal, prescription only cream for the treatment of seborrheic dermatitis. It has demonstrated anti-inflammatory and anti-fungal properties. Sebclair is approved for use in the European Union to treat seborrheic dermatitis. One of Sebclair’s (and now Promiseb’s) claims to fame is that it contains no corticosteroids or immunomodulating agents.

The ingredients of Sebclair are listed here: Sebclair for seborrheic dermatitis. See also the Promiseb Prescribing Information.

An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.

Clin Dermatol. 2009 Nov-Dec;27(6 Suppl):S48-53., Elewski B.

The treatment of seborrheic dermatitis includes topical antifungal agents to eradicate Malassezia spp, corticosteroids, which treat the inflammatory component of the disease and keratolytics which remove scale and crust.

This study compared the efficacy of a nonsteroidal topical cream and a low-potency topical corticosteroid for the treatment of mild to moderate seborrheic dermatitis of the face in 77 volunteers randomized to twice-daily treatment with nonsteroidal cream or corticosteroid cream for up to 28 days. If the individual was rated clear by day 14, the study drug was collected and the participant was told not to use any topical products on the previously treated areas until after the 28-day follow-up visit.

Both treatments were similarly effective in reducing disease severity, with approximately 90% of participants clearing or almost clear during the study. Both treatments demonstrated significant reductions in erythema, scaling, and pruritus (P < .0001). Safety in both groups was rated as excellent in more than 90%.

Those using the nonsteroidal cream who cleared after 14 days of treatment were more likely to remain clear than were participants using the corticosteroid cream (P = .0173). [my emphasis]

Investigator global assessments of improvement found both study agents were essentially the same, and participants in both groups achieved clinically important improvement.

Sebclair launches as Promiseb Cream

David Pascoe — Tue, 11 Aug 2009 01:55:48 +0000

I was alerted to the launch of a product called Promiseb by a comment left on the Sebclair for Seborrheic Dermatitis post. Since then the news web sites are also covering the press release. Promiseb (probably pronounced Promi-seb) is launching in the U.S. via Promius Pharma, after being licensed from Sinclair Pharma in 2007.

Promiseb is claimed to “Significantly reduced Malassezia yeasts, the organisms that may cause seborrheic dermatitis, by 94%”. These claims are more interesting when you consider the ongoing discussions like Malassezia Globosa causes seborrhea, Pyrithione Zinc is effective, Could M. Globosa Cause Rosacea? and Real cause of seborrhea discovered!.

For a description of the ingredients and suggested method of action see Sebclair for seborrheic dermatitis.

From the press release: Sebclair launched in the US by Dr Reddy’s Laboratories’ subsidiary Promius Pharma, LLC

Jeff Wasserstein, President of Promius Pharma, said “We are very excited about Promiseb Cream because it has the potential to replace both anti-inflammatoryand antifungal treatments in patients with seborrheic dermatitis. In a clinicalstudy Promiseb was shown to have efficacy comparable to desonide cream 0.05% atdays 14 and 28 with fewer relapses.

“Promiseb Cream also has an excellent safety profile with no restrictions onage, duration of use or application on the face.” He continued, “We are very enthusiastic about this product because our clinical research shows thatPromiseb Cream may be used as a first-line treatment for seborrheic flares andfor long-term maintenance”

A supporting web site for Promiseb is online at http://promiseb.com/.

[update:] Auburn-NH has posted an early review of Promiseb, from using a doctor supplied sample.

seborrheic dermatitis: state of the art, finacea 3 stars

David Pascoe — Mon, 23 Feb 2009 02:56:05 +0000

This paper summarises the current state of the art for seborrheic dermatitis – research and treatment options. The author mentions recent research that links seborrheic dermatitis with a spore known as Malassezia Globosa. He makes the point that azelaic acid, as found in finacea contains agents that give it anti-inflammatory, antikeratinizing and antifungal properties; 3 properties felt to be important in battling seborrheic dermatitis. As finacea also helps the papules and pustules of rosacea, and some rosacea sufferers have rosacea combined with seborrheic dermatits, it is a product worth keeping in your treatment arsenal.

Residents of Australia may not know that Finacea is available Over The Counter. See also the ongoing comment thread on the Rosacea News item: focus on finacea.

Facial seborrheic dermatitis: a report on current status and therapeutic horizons, J Drugs Dermatol. 2009 Feb;8(2):125-33, Bikowski J

Seborrheic dermatitis, characterized by erythema and/or flaking or scaling in areas of high sebaceous activity, affects up to 5% of the US population and often appears in conjunction with other common skin disorders, such as rosacea and acne. Despite ongoing research, its etiology is puzzling. Increased sebaceous and hormonal (androgenic) activity is thought to play a part. Recent evidence suggests an important role for individual susceptibility to irritant metabolites of the skin commensal Malassezia, most probably M globosa. Current approaches thus include agents with antifungal as well as antikeratinizing, and anti-inflammatory activity. Azelaic acid, which has all 3 properties, may be a useful addition to first-line management, which now comprises of topical steroids, the immunosuppressant agents tacrolimus and pimecrolimus, azoles and other antifungals, and keratolytic agents. A recent exploratory study supports the efficacy and safety of azelaic acid 15% gel in seborrheic dermatitis. Azelaic acid may be especially valuable in this application because of its efficacy in treating concomitant rosacea and acne.

Sebclair / Atopiclair available in Australia

David Pascoe — Tue, 10 Feb 2009 04:36:24 +0000

It looks like Australians can easily get this preparation via mail and pay via paypal.

It appears to be called Atopiclair and is available from
http://www.atopiclair.com.au/ It is listed as Atopiclair Cream 40ml and is $49 including postage to anywhere in Australia.

The web site claims a “new, non-steroidal cream that is designed to relieve the symptoms and signs of eczema (atopic dermatitis) and allergic dermatitis (contact dermatitis).”

Going by the papers they cite on that page and the paper above both quoting MAS063DP (Atopiclair[TM]), and the fact that Otco Global is listed as the Australian distributor – I’d say that this is Sebclair.

Sebclair (MAS064D) is approved for use in the European Union to treat seborrheic dermatitis. One of Sebclair’s claim to fame is that it contains no corticosteroids or immunomodulating agents. The paper’s authors admit that it is difficult to know which compound is responsible for Sebclair’s success as a treatment.

The authors state “We believe that the major activity is probably due to the synergistic effect of both piroctone olamine, for its antimycotic action, and glycyrrhetinic acid, for its anti-inflammatory action.”

NRS on seborrheic dermatitis

David Pascoe — Thu, 02 Oct 2008 01:03:13 +0000

The National Rosacea Society web site has just uploaded a page on Seborrheic Dermatitis ;

Although the two disorders are unrelated, a recent clinical study found that 26 percent of patients with rosacea also had facial seborrheic dermatitis and 28 percent had seborrheic dermatitis of the scalp. Additionally, a survey by the National Rosacea Society of 1,100 rosacea patients found that 25 percent had also been diagnosed with this condition.

…

When seborrheic dermatitis appears with rosacea, a safe and effective antifungal alone may often be prescribed because the long-term use of topical steroids is associated with rosacea-like symptoms. This condition is known as steroid-induced rosacea. Treatment of seborrheic dermatitis of the scalp may include medicated anti-dandruff shampoos.

Rosacea patients who suspect they may have this disorder are urged to see a dermatologist for diagnosis and appropriate treatment.

Nothing too ground breaking, but it is good to see the NRS writing about SD as it is so common for rosacea sufferers.

metrogel also works for seborrheic dermatitis

David Pascoe — Tue, 13 May 2008 02:30:14 +0000

This paper found that 0.75% metrogel worked just as well as ketoconazole 2% cream in treating SD. The study found that both were able to offer significant improvement with similar side effects. The authors suggest that because there is so little evidence of anti fungal activity of metronidazole, it is difficult to speculate that this is the reason for its efficacy in treating SD. Patients with rosacea were excluded from this study, so there is a good finding here that even if you only suspect that you have seborrheic dermatitis, metrogel is a good opening treatment option.

Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study, D Seckin, O Gurbuz, O Akin, JEADV, Volume 21 Issue 3 Page 345-350, March 2007.

Background: Recently, two placebo-controlled studies have shown that topical metronidazole was effective in the treatment of seborrheic dermatitis.

Objective: To compare the efficacy and safety of metronidazole 0.75% gel with that of ketoconazole 2% cream in the treatment of facial seborrheic dermatitis.

Methods: A total of 60 consecutive patients with facial seborrheic dermatitis were included. Patients were randomized into two groups. One group used ketoconazole 2% cream with metronidazole gel as vehicle; the other group used metronidazole 0.75% gel with ketoconazole cream as vehicle for a 4-week treatment period. Main outcome measures were change in clinical severity scores, patients’ and investigator’s global evaluation of improvement and frequency of side-effects.

Results: All the assessments were made by an investigator who was unaware of which group the patients were allocated to. Mean percentage decrease in clinical severity scores from baseline to last available visit was 63.4% (95% CI 57.7–69) and 54.4% (95% CI 47.9–61) in the ketoconazole- and metronidazoletreated patients, respectively (P = 0.31). Eighty-two per cent of patients in the ketoconazole group vs. 79% of patients in the metronidazole group rated their global improvement as significant or moderate (P > 0.05). No statistically significant difference in the frequency of side-effects was detected between the two groups. The results of this study need to be confirmed in further studies involving large numbers of patients.

Conclusion: Our data demonstrated that metronidazole 0.75% gel had a comparable efficacy and safety profile with that of ketoconazole 2% cream in the treatment of facial seborrheic dermatitis.

Sebclair for seborrheic dermatitis

David Pascoe — Thu, 08 May 2008 11:44:10 +0000

This recently published paper investigates the effectiveness of a `novel steroid-free cream containing multiple active ingredients’, called Sebclair to treat facial seborrheic dermatitis.

This product sounds quite interesting for rosacea and rosacea/SD sufferers. Little information about Sebclair is currently available on the internet.

Sebclair Ingredients

Ingredient	Concentration	Role
Isohexadecane	8%	Emollient
Shea butter	6%	Emollient
Bisabolol	1.2%	Anti-inflammatory
Piroctone olamine	1%	Antimycotic
Alglycera	1%	Anti-inflammatory and keratolytic
Vitamin E	1%	Anti-inflammatory and antioxidant
Allantoin	0.35%	Keratolytic
V. vinifera	0.1%	Anti-oxidant
Telmesteine	0.01%	Anti-inflammatory and antioxidant

The following descriptions of each ingredient is supplied in the full text of the paper.

Alglycera is a compound combining the anti-inflammatory properties of glycyrrhetinic acid and the keratolytic properties of allantoin.

Glycyrrhetinic acid, extracted from the licorice root, exhibits anti-inflammatory properties in different organs in several animal models,
with a potency similar to that of indomethacine. Its chemical structure is similar to that of cortisone and has been shown to potentiate the action of hydrocortisone

Piroctone olamine is an antimycotic effective against Malassezia spp.

The standardized extract of V. vinifera (grapevine) in Sebclair contains 40% of epigallocatechin gallate, a proanthocyanidine that prevents oxidative damage to the endothelium, with maintenance of optimal blood supply. It works as an antioxidant synergistically with telmesteine and Vitamin E.

Shea butter, from Butyrospermum parkii, is composed of tryglycerides and fatty acids, including linoleic acid, rich in phytosterols and tocopherols. The action of shea butter is enhanced by isohexedecane, another emollient present in the formulation.

If you live in the EU and suffer from SD, please do let us know how you like Sebclair, but leaving a comment below.

Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial, J Eur Acad Dermatol Venereol. 2008 Mar;22(3):290-6. S Veraldi, A Menter, M Innocenti, Institute of Dermatological Sciences, University of Milan, IRCCS Foundation, Policlinico, Mangiagalli and Regina Elena Hospital, Milan, Italy; Baylor University Medical Centre, Dallas, TX, USA, European Institute of Dermatology, Milan, Italy

Aim: MAS064D (Sebclair) is a novel steroid-free cream containing multiple active ingredients. Objective of this pilot study was to evaluate the efficacy and safety of MAS064D in the treatment of mild to moderate SD of the face.
Methods: Patients (n= 60) with SD were randomized to receive MAS064D (n= 40) or a matching vehicle (n = 20). The primary study endpoint was investigators’ global assessment (IGA) score at day 28, compared with baseline. Secondary endpoints included: IGA score at day 14; investigators’ assessment of erythema and scaling; patients’ assessment of burning/stinging, pruritus and global response to MAS064D; resort to rescue medication; quality of life.
Results: Use of MAS064D for 4 weeks was associated with a higher percentage of success in the MAS064D group than in the vehicle group (~68% vs 11%, P < 0.0001). The effects of MAS064D were significantly better than those of vehicle for investigator-assessed erythema and scaling, and patients’ assessed pruritus and global response to MAS064D (P ≤ 0.01). No patient in the MAS064D
group required rescue medication, compared with two patients in the vehicle group. Four patients (two each in the MAS064D and vehicle groups) reported a total of six non-serious adverse events.
Conclusions: MAS064D appears to be an effective and well tolerated cream for the treatment of mild to moderate SD of the face. Further clinical evaluation of MAS064D in SD is warranted.

Update: Sebclair has launched as Promiseb Cream in the United States.

Sinclair Pharma: Sebclair

Clarisonic user reviews

David Pascoe — Wed, 20 Feb 2008 03:41:20 +0000

With the recent push by Clarisonic to promote their sonic brush as treatment for rosacea, I thought it might be interesting to see some reviews of users of the Clarisonic Skin Care System by rosacea sufferers. Although it is expensive, it does seem to be working quite well and so far no-one is reporting that it has irritated their skin. This is a bit of a surprise to me, that it is seemingly so well tolerated.

If you try it, please do let us know what you think. Leave a comment at the end of this post.

Yvette on Tue 10 Apr 2007 said,

I bought the Clarisonic brush about a week or two ago. I was nervous to use it at first because I did see conflicting notes about whether it’s okay for Rosacea. On the Clarisonic website it does have some pic’s for those with Rosacea and mild acne and that it’s okay to use. However, in the brochure that comes with the Clarisonic, it stated, if you have a skin condition (which Rosacea and acne are especially named) ask your health care professional before use.

I asked my Derm’s office (P.A.) and she hadn’t heard of it. Even my aesthetician hadn’t heard of it. Both my Derm. and aesthetician said to be cautious and don’t be over zealous with it. The brush comes with a sensitive brush and a normal skin brush. It says you can use twice a day. I’ve used only once a day, mainly in the morning, and it does seem to do a better job cleansing my skin versus by hand. The sensitive brush is very soft and doesn’t irritate. If I have a pimple (one with fluid) I avoid brushing. I wouldn’t recommend at all if you have active acne or pustular bumps; if pimples somehow pop while using the brush the germs will get on the brush and you can carry them to other areas of the face and more acne could result. Overall, my face is MUCH softer and cleaner after use. After I clean my face with the Clarisonic, I give my face several splashes of water. I rinse the brush in hot water each time and deep clean (in antibacterial soap) every few days. Over the past week, the texture of my skin has improved and my pores are cleaner. I don’t have any increased redness or irritation. My makeup goes on better and lasts longer too.

I just want to add the sensitive brush is very soft and when used it feels like a soft plushy towel is cleaning your face. Previously, I washed using my hands, but found sometimes my face wasn’t really clean. The brush bristles move in circular oscillating motions to work “with your skin” versus pulling it. The slight bumps (probably clogged pores) I had on my jaw line a few weeks ago are nearly gone. My face is definitely smoother and I have less bumps and clogged pores. I still get a few breakouts on my chin and try to avoid using the Clarisonic on this area until healed. When using, I use a very gentle non-soap cleanser (MD Forte non soap cleanser or Christine Chin sulfate free Ultra Calming Gel cleanser).

rosesarered on Sat 14 Apr 2007 said,

At any rate, it continues to seem to improve my skin pretty dramatically. I’ll say just briefly what my own skin is like, in the hopes that that might help others considering Clarisonic decide whether it’d be right for them. I have dry, dry skin with tiny flakes on my cheeks and nose. I have enlarged pores on my cheeks, and some permanent redness, accompanied by occasional flushes. In the past, my skin has responded favourably to exfoliants like Pond’s Purely Polished when VERY gently, carefully, and infrequently applied. My skin’s response to the exfoliant was one of the things that made me optimistic about Clarisonic, which seemed like a much gentler and chemical-free way to accomplish the same ends.

az21300 said on Fri 25 May 2007

I have been using the clarisonic brush for about a month and a half now. its amazing. it comes with a sensitive brush and and normal brush. i have now worked my way up to the normal brush and my skin is loving it. I use it twice a day with a CVS version of cetaphil. i find that my skin is about 2X’s as smooth as it was prior. it obviously hasn’t cured my rosacea but has helped a lot…

sprtmrg said on 24 Feb 2007,

I’ve tried it and found it to be very helpful. A spa I went to recommended it to me. At first I was not interested because I thought it would be too harsh for my sensitive skin. They had a whole box of of the delicate (blue) brush heads that they had gotten from the rep. They let me use their system with a new brush head to try it out and see if I liked it. My skin felt baby soft and smooth afterward.
I purchased the system in November for $150. They gave me a free blue brush head. The system comes with both white and gray but the blue is the most delicate. When you buy the system you also get a free one year subscription to Health magazine and a coupon good for two free brush heads, plus a coupon for a buy one get one brush head. I called the company and asked if I could get the blue and they said okay. The brush heads are $25 each full price. My skin type is oily with large pores and I tend to get a little bit of seb derm. I also get what seems like little bits of sand stuck inside my pores (chicken skin). This works miracles for that. My skin is softer and smoother and I’ve been using it since November. The seb derm is also gone and the machine has never made me turn red. Many things do but not the Clarisonic. The difference in the skin is like the difference between brushing your teeth or using one of those electric toothbrush systems (I use the Braun).

During this time I’ve been undergoing laser genesis treatments. If your doctor’s office has one you might be able to get a good deal. I hear Nordstrom sells the machines too and they have a very good return policy. I would think anyone with oily skin could give this a try but maybe those with very dry skin might need to be more careful. I’m not in any way affiliated with Clarisonic or get any type of benefit for promoting their product. I’ve tried so many things out there and this really seems to work for me. I hope this can help someone else too.

Featured Product

[Update] Clarisonic have now released the Clarisonic Mia, a cheaper less-frills version of the Clarisonic Skincare System.

Rosacea Support Group » seborrheic dermatitis

Extina, Ketoconazole you can use on your face

Related Articles

Clarifoam EF good for Rosacea, Acne and Seborrheic Dermatitis

User Reviews

Related Articles

Promiseb even better than Desonide 0.05%

Related Articles

Sebclair launches as Promiseb Cream

Related Articles

seborrheic dermatitis: state of the art, finacea 3 stars

Related Articles

Sebclair / Atopiclair available in Australia

Related Articles

NRS on seborrheic dermatitis

Related Articles

metrogel also works for seborrheic dermatitis

Related Articles

Sebclair for seborrheic dermatitis

Related Articles

Clarisonic user reviews

Featured Product

Related Articles

Related Articles

An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
David Pascoe — Thu, 26 Nov 2009 01:47:06 +0000

Facial seborrheic dermatitis: a report on current status and therapeutic horizons
David Pascoe — Mon, 23 Feb 2009 02:56:05 +0000

Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial
David Pascoe — Thu, 08 May 2008 11:44:10 +0000